Terms: = Brain cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Treatment
49 results:
1. Spatial and temporal heterogeneity of tumor immune microenvironment between primary tumor and brain metastases in NSCLC.
Liu JS; Cai YX; He YZ; Xu J; Tian SF; Li ZQ
BMC Cancer; 2024 Jan; 24(1):123. PubMed ID: 38267913
[TBL] [Abstract] [Full Text] [Related]
2. The iron chelator and OXPHOS inhibitor VLX600 induces mitophagy and an autophagy-dependent type of cell death in glioblastoma cells.
Reisbeck L; Linder B; Tascher G; Bozkurt S; Weber KJ; Herold-Mende C; van Wijk SJL; Marschalek R; Schaefer L; Münch C; Kögel D
Am J Physiol Cell Physiol; 2023 Dec; 325(6):C1451-C1469. PubMed ID: 37899749
[TBL] [Abstract] [Full Text] [Related]
3. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages.
Fan Y; Gao Z; Xu J; Wang H; Guo Q; Li B; Li M; Xu H; Qi Y; Zhao S; Qiu W; Pan Z; Wang Q; Xue H; Zhao R; Guo X; Li G
Theranostics; 2023; 13(10):3310-3329. PubMed ID: 37351164
[No Abstract] [Full Text] [Related]
4. Intracranial Activity of Selpercatinib in Chinese Patients With Advanced
Cheng Y; Huang D; Zhou J; Zhou C; Sun Y; Wu L; Guo Y; Jingxin S; Zhang W; Lu S
JCO Precis Oncol; 2023 Jun; 7():e2200708. PubMed ID: 37315261
[TBL] [Abstract] [Full Text] [Related]
5. Normofractionated irradiation and not temozolomide modulates the immunogenic and oncogenic phenotype of human glioblastoma cell lines.
Schatz J; Ladinig A; Fietkau R; Putz F; Gaipl US; Frey B; Derer A
Strahlenther Onkol; 2023 Dec; 199(12):1140-1151. PubMed ID: 36480032
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer.
O'Shaughnessy J; Brufsky A; Rugo HS; Tolaney SM; Punie K; Sardesai S; Hamilton E; Loirat D; Traina T; Leon-Ferre R; Hurvitz SA; Kalinsky K; Bardia A; Henry S; Mayer I; Zhu Y; Phan S; Cortés J
Breast Cancer Res Treat; 2022 Sep; 195(2):127-139. PubMed ID: 35545724
[TBL] [Abstract] [Full Text] [Related]
7. Successful osimertinib rechallenge following subsequent chemotherapy regimen in a patient with metastatic non-small cell lung carcinoma: a case report.
Han ZJ; Luo N; Li L; Liu ZL
Ann Palliat Med; 2021 Jul; 10(7):8413-8419. PubMed ID: 33977727
[TBL] [Abstract] [Full Text] [Related]
8. Glioblastomas harboring gene fusions detected by next-generation sequencing.
Woo HY; Na K; Yoo J; Chang JH; Park YN; Shim HS; Kim SH
Brain Tumor Pathol; 2020 Oct; 37(4):136-144. PubMed ID: 32761533
[TBL] [Abstract] [Full Text] [Related]
9. Predictive value of neuron-specific enolase, neutrophil-to-lymphocyte-ratio and lymph node metastasis for distant metastasis in small cell lung cancer.
Xia X; Li K; Wu R; Lv Q; Deng X; Fei Z; Zou C; Yang X
Clin Respir J; 2020 Nov; 14(11):1060-1066. PubMed ID: 32750207
[TBL] [Abstract] [Full Text] [Related]
10. Antioxidant, Anti-Inflammatory and Cytotoxic Properties of
Hadjira S; Mansour A; Berkel C; Seghiri R; Menad A; Benayache F; Benayache S; Cacan E; Ameddah S
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(1):89-100. PubMed ID: 32516104
[TBL] [Abstract] [Full Text] [Related]
11. Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma.
Das A; Henderson F; Lowe S; Wallace GC; Vandergrift WA; Lindhorst SM; Varma AK; Infinger LK; Giglio P; Banik NL; Patel SJ; Cachia D
Cancer Chemother Pharmacol; 2018 Dec; 82(6):945-952. PubMed ID: 30209569
[TBL] [Abstract] [Full Text] [Related]
12. Molecular subgroups and B7-H4 expression levels predict responses to dendritic cell vaccines in glioblastoma: an exploratory randomized phase II clinical trial.
Yao Y; Luo F; Tang C; Chen D; Qin Z; Hua W; Xu M; Zhong P; Yu S; Chen D; Ding X; Zhang Y; Zheng X; Yang J; Qian J; Deng Y; Hoon DSB; Hu J; Chu Y; Zhou L
Cancer Immunol Immunother; 2018 Nov; 67(11):1777-1788. PubMed ID: 30159779
[TBL] [Abstract] [Full Text] [Related]
13. Midazolam and Dexmedetomidine Affect Neuroglioma and Lung Carcinoma Cell Biology In Vitro and In Vivo.
Wang C; Datoo T; Zhao H; Wu L; Date A; Jiang C; Sanders RD; Wang G; Bevan C; Ma D
Anesthesiology; 2018 Nov; 129(5):1000-1014. PubMed ID: 30157038
[TBL] [Abstract] [Full Text] [Related]
14. Mir-758-5p Suppresses Glioblastoma Proliferation, Migration and Invasion by Targeting ZBTB20.
Liu J; Jiang J; Hui X; Wang W; Fang D; Ding L
Cell Physiol Biochem; 2018; 48(5):2074-2083. PubMed ID: 30099442
[TBL] [Abstract] [Full Text] [Related]
15. A phase I study of panobinostat in pediatric patients with refractory solid tumors, including CNS tumors.
Wood PJ; Strong R; McArthur GA; Michael M; Algar E; Muscat A; Rigby L; Ferguson M; Ashley DM
Cancer Chemother Pharmacol; 2018 Sep; 82(3):493-503. PubMed ID: 29987369
[TBL] [Abstract] [Full Text] [Related]
16. B7-H6 expression is induced by lipopolysaccharide and facilitates cancer invasion and metastasis in human gliomas.
Che F; Xie X; Wang L; Su Q; Jia F; Ye Y; Zang L; Wang J; Li H; Quan Y; You C; Yin J; Wang Z; Li G; Du Y; Wang L
Int Immunopharmacol; 2018 Jun; 59():318-327. PubMed ID: 29679856
[TBL] [Abstract] [Full Text] [Related]
17. Depressive symptoms predict head and neck cancer survival: Examining plausible behavioral and biological pathways.
Zimmaro LA; Sephton SE; Siwik CJ; Phillips KM; Rebholz WN; Kraemer HC; Giese-Davis J; Wilson L; Bumpous JM; Cash ED
Cancer; 2018 Mar; 124(5):1053-1060. PubMed ID: 29355901
[TBL] [Abstract] [Full Text] [Related]
18. TIE2 Associates with Caveolae and Regulates Caveolin-1 To Promote Their Nuclear Translocation.
Hossain MB; Shifat R; Li J; Luo X; Hess KR; Rivera-Molina Y; Puerta Martinez F; Jiang H; Lang FF; Hung MC; Fueyo J; Gomez-Manzano C
Mol Cell Biol; 2017 Nov; 37(21):. PubMed ID: 28760776
[TBL] [Abstract] [Full Text] [Related]
19. Inter-alpha Inhibitor H4 as a Potential Biomarker Predicting the treatment Outcomes in Patients with Hepatocellular Carcinoma.
Lee EJ; Yang SH; Kim KJ; Cha H; Lee SJ; Kim JH; Song J; Chun KH; Seong J
Cancer Res Treat; 2018 Jul; 50(3):646-657. PubMed ID: 28724284
[TBL] [Abstract] [Full Text] [Related]
20. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
[TBL] [Abstract] [Full Text] [Related]
[Next]
